Bjoern O. Schelter
Meston Walk
Aberdeen, SCT, United Kingdom
Aberdeen, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data.
Journal: The journal of prevention of Alzheimer's disease
Published: October 07, 2025
Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease.
Journal: The journal of prevention of Alzheimer's disease
Published: October 01, 2025
Hypertension is the Main Vascular Risk Factor for Cognitive Impairment, Microvascular Pathology and Brain Atrophy in Alzheimer's Disease.
Journal: Current Alzheimer research
Published: April 18, 2025
Hypertension is the Main Vascular Risk Factor for Cognitive Impairment, Microvascular Pathology and Brain Atrophy in Alzheimer's Disease.
Journal: Current Alzheimer research
Published: April 18, 2025
Atypical population pharmacokinetics of hydromethylthionine in patients with Alzheimer's disease explains unexpected phase 3 trial results.
Journal: British journal of clinical pharmacology
Published: April 07, 2025
Obtaining personalized predictions from a randomized controlled trial on Alzheimer's disease.
Journal: Scientific reports
Published: September 24, 2024
FDG-PET Image Classification in Alzheimer's Disease: from Traditional Visual Analysis to Advanced Transfer Learning.
Journal: Nuclear medicine and molecular imaging
Published: September 11, 2024
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate.
Journal: The journal of prevention of Alzheimer's disease
Published: October 25, 2022
Crossed cerebellar diaschisis in Alzheimer's disease.
Journal: Nuclear medicine communications
Published: January 26, 2022
Inferring the underlying multivariate structure from bivariate networks with highly correlated nodes.
Journal: Scientific reports
Published: November 26, 2021
Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier.
Journal: Journal of Alzheimer's disease : JAD
Published: August 09, 2021
On the Validity of Neural Mass Models.
Journal: Frontiers in computational neuroscience
Published: July 07, 2020
Last Updated: 09/26/2026